methadone has been researched along with metyrapone in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Albeck, H; Hartman, N; Kennedy, JA; Khuri, E; Kreek, MJ; Sbriglio, R | 1 |
Caccavari, R; Gerra, G; Girasole, G; Maestri, D; Maninetti, L; Michelini, M; Passeri, M; Pedrazzoni, M; Pioli, G; Vescovi, PP | 1 |
Hartman, N; Kennedy, JA; Khuri, E; Kreek, MJ; Sbriglio, R | 1 |
Ditzler, J; Northrop, G; Ryan, WG; Wilbanks, GD | 1 |
Bordier, B; Cushman, P; Hilton, JG | 1 |
Hamer, D; Hartman, N; Kreek, MJ; Plevy, S; Ragunath, J; Schneider, B | 1 |
Borg, L; Ho, A; Kreek, MJ; Schluger, JH | 1 |
1 review(s) available for methadone and metyrapone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for methadone and metyrapone
Article | Year |
---|---|
Hypothalamic-pituitary-adrenal axis in methadone-treated heroin addicts.
Topics: 17-Hydroxycorticosteroids; Adult; Clinical Trials as Topic; Corticotropin-Releasing Hormone; Feedback; Glucocorticoids; Heroin; Humans; Hypoglycemia; Hypothalamo-Hypophyseal System; Insulin; Male; Methadone; Metyrapone; Middle Aged; Periodicity; Pituitary-Adrenal System; Stress, Physiological; Substance-Related Disorders | 1970 |
7 other study(ies) available for methadone and metyrapone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patients.
Topics: Female; Humans; Male; Methadone; Metyrapone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1990 |
Metyrapone effects on beta-endorphin, ACTH and cortisol levels after chronic opiate receptor stimulation in man.
Topics: Adrenocorticotropic Hormone; Adult; beta-Endorphin; Heroin Dependence; Humans; Hydrocortisone; Male; Methadone; Metyrapone; Receptors, Opioid; Reference Values; Substance-Related Disorders | 1990 |
Metyrapone-induced withdrawal symptoms.
Topics: Adult; Female; Heroin Dependence; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methadone; Metyrapone; Pituitary-Adrenal System; Substance Withdrawal Syndrome | 1990 |
Estriol excretion profiles in narcotic-addicted pregnant women.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Birth Weight; Dexamethasone; Estriol; Female; Heroin; Humans; Infant, Newborn; Methadone; Metyrapone; Parity; Pregnancy; Pregnancy Complications; Substance Withdrawal Syndrome; Substance-Related Disorders | 1972 |
ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans.
Topics: Adrenocorticotropic Hormone; beta-Endorphin; Endorphins; Female; Hormones; Humans; Hydrocortisone; Male; Methadone; Metyrapone; Substance-Related Disorders | 1984 |
Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cocaine-Related Disorders; Female; Heroin Dependence; Humans; Hypothalamo-Hypophyseal System; Male; Methadone; Metyrapone; Middle Aged; Narcotics; Pituitary-Adrenal System; Stress, Physiological | 2001 |